ESET Foundation: Επιστήμονες από τις εταιρείες MultiplexDX, Lambda Life και ProScience Tech της Σλοβακίας ένωσαν τις δυνάμεις τους με ιολόγους του Βιοϊατρικού Ερευνητικού Κέντρου της Σλοβακικής Ακαδημίας Επιστημών BMC SAV για την ανάπτυξη αντιδραστηρίων με βάση τα πρωτόκολλα του Παγκόσμιου Οργανισμού Υγείας (Π.Ο.Υ.) για την αξιόπιστη ανίχνευση του ιού SARS-CoV-2.
In the first phase, they plan to produce and make available 100.000 diagnostic kits which the ESET Foundation will fund and offer to government of Slovakia.
Decisive in the project is the contribution of the company MultiplexDX, which specializes in the development and manufacture of innovative molecular diagnostic reagents. At the present stage, the Slovak PCR test is being tested with the cooperation team of BMC SAV scientists.
According to preliminary results, the new diagnostic test works satisfactorily and shows good sensitivity compared to the available ones diagnostic methods.
"This means that the diagnostic test we are preparing is reliable and accurate and can help diagnose the disease at an early stage. We can develop in two weeks what is needed to produce 100.000 diagnostic tests, "said Pavol Čekan, founder of MultiplexDX.
"For the process of evaluating and reporting the results of the research, we work with the non-profit organization CCCT SK. According to estimates, this stage will take about three weeks, "said Adam Andráško of ProScience Tech.
"Virus detection includes sampling, RNA isolation and PCR diagnosis, with the joint effort to focus on the final stage," said Ivan Juráš of Lambda Life
The entire production, including the first 100.000 diagnostic kits, will initially be made available to diagnostic laboratories in Slovakia.
"We are ready to cooperate with state laboratories, responding immediately to their needs and supplying them with sufficient quantities. "Once we meet the needs of the Slovak laboratories, we will be able to distribute quantities in other countries that may need our products," explain the test creators.
